Global HER2-negative Breast Cancer Market Research Report Forecast 2017 to 2022

November 2017 | 108 pages | ID: G64DF3238A6EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Global HER2-negative Breast Cancer Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the HER2-negative Breast Cancer industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This HER2-negative Breast Cancer market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global HER2-negative Breast Cancer Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
F. Hoffmann-La Roche
Novartis
Pfizer
AbbVie
AstraZeneca
BioMarin
Bristol-Myers Squibb
Eisai
Eli Lilly

Global HER2-negative Breast Cancer Market: Product Segment Analysis
Type 1
Type 2
Type 3


Global HER2-negative Breast Cancer Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 HER2-NEGATIVE BREAST CANCER MARKET OVERVIEW

1.1 Product Overview and Scope of HER2-negative Breast Cancer
1.2 HER2-negative Breast Cancer Market Segmentation by Type
  1.2.1 Global Production Market Share of HER2-negative Breast Cancer by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 HER2-negative Breast Cancer Market Segmentation by Application
  1.3.1 HER2-negative Breast Cancer Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 HER2-negative Breast Cancer Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of HER2-negative Breast Cancer (2012-2022)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON HER2-NEGATIVE BREAST CANCER INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL HER2-NEGATIVE BREAST CANCER MARKET COMPETITION BY MANUFACTURERS

3.1 Global HER2-negative Breast Cancer Production and Share by Manufacturers (2015 and 2016)
3.2 Global HER2-negative Breast Cancer Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global HER2-negative Breast Cancer Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers HER2-negative Breast Cancer Manufacturing Base Distribution, Production Area and Product Type
3.5 HER2-negative Breast Cancer Market Competitive Situation and Trends
  3.5.1 HER2-negative Breast Cancer Market Concentration Rate
  3.5.2 HER2-negative Breast Cancer Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL HER2-NEGATIVE BREAST CANCER PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global HER2-negative Breast Cancer Production by Region (2012-2017)
4.2 Global HER2-negative Breast Cancer Production Market Share by Region (2012-2017)
4.3 Global HER2-negative Breast Cancer Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL HER2-NEGATIVE BREAST CANCER SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global HER2-negative Breast Cancer Consumption by Regions (2012-2017)
5.2 North America HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL HER2-NEGATIVE BREAST CANCER PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global HER2-negative Breast Cancer Production and Market Share by Type (2012-2017)
6.2 Global HER2-negative Breast Cancer Revenue and Market Share by Type (2012-2017)
6.3 Global HER2-negative Breast Cancer Price by Type (2012-2017)
6.4 Global HER2-negative Breast Cancer Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL HER2-NEGATIVE BREAST CANCER MARKET ANALYSIS BY APPLICATION

7.1 Global HER2-negative Breast Cancer Consumption and Market Share by Application (2012-2017)
7.2 Global HER2-negative Breast Cancer Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL HER2-NEGATIVE BREAST CANCER MANUFACTURERS ANALYSIS

8.1 F. Hoffmann-La Roche
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Novartis
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Pfizer
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 AbbVie
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 AstraZeneca
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 BioMarin
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Bristol-Myers Squibb
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Eisai
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Eli Lilly
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 HER2-NEGATIVE BREAST CANCER MANUFACTURING COST ANALYSIS

9.1 HER2-negative Breast Cancer Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of HER2-negative Breast Cancer

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 HER2-negative Breast Cancer Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of HER2-negative Breast Cancer Major Manufacturers in 2016
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL HER2-NEGATIVE BREAST CANCER MARKET FORECAST (2017-2022)

13.1 Global HER2-negative Breast Cancer Production, Revenue Forecast (2017-2022)
13.2 Global HER2-negative Breast Cancer Production, Consumption Forecast by Regions (2017-2022)
13.3 Global HER2-negative Breast Cancer Production Forecast by Type (2017-2022)
13.4 Global HER2-negative Breast Cancer Consumption Forecast by Application (2017-2022)
13.5 HER2-negative Breast Cancer Price Forecast (2017-2022)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of HER2-negative Breast Cancer
Figure Global Production Market Share of HER2-negative Breast Cancer by Type in 2016
Table HER2-negative Breast Cancer Consumption Market Share by Application in 2016
Figure North America HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure China HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure India HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global HER2-negative Breast Cancer Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global HER2-negative Breast Cancer Capacity of Key Manufacturers (2015 and 2016)
Table Global HER2-negative Breast Cancer Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global HER2-negative Breast Cancer Capacity of Key Manufacturers in 2015
Figure Global HER2-negative Breast Cancer Capacity of Key Manufacturers in 2016
Table Global HER2-negative Breast Cancer Production of Key Manufacturers (2015 and 2016)
Table Global HER2-negative Breast Cancer Production Share by Manufacturers (2015 and 2016)
Figure 2015 HER2-negative Breast Cancer Production Share by Manufacturers
Figure 2016 HER2-negative Breast Cancer Production Share by Manufacturers
Table Global HER2-negative Breast Cancer Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global HER2-negative Breast Cancer Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global HER2-negative Breast Cancer Revenue Share by Manufacturers
Table 2016 Global HER2-negative Breast Cancer Revenue Share by Manufacturers
Table Global Market HER2-negative Breast Cancer Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market HER2-negative Breast Cancer Average Price of Key Manufacturers in 2016
Table Manufacturers HER2-negative Breast Cancer Manufacturing Base Distribution and Sales Area
Table Manufacturers HER2-negative Breast Cancer Product Type
Figure HER2-negative Breast Cancer Market Share of Top 3 Manufacturers
Figure HER2-negative Breast Cancer Market Share of Top 5 Manufacturers
Table Global HER2-negative Breast Cancer Capacity by Regions (2012-2017)
Figure Global HER2-negative Breast Cancer Capacity Market Share by Regions (2012-2017)
Figure Global HER2-negative Breast Cancer Capacity Market Share by Regions (2012-2017)
Figure 2015 Global HER2-negative Breast Cancer Capacity Market Share by Regions
Table Global HER2-negative Breast Cancer Production by Regions (2012-2017)
Figure Global HER2-negative Breast Cancer Production and Market Share by Regions (2012-2017)
Figure Global HER2-negative Breast Cancer Production Market Share by Regions (2012-2017)
Figure 2015 Global HER2-negative Breast Cancer Production Market Share by Regions
Table Global HER2-negative Breast Cancer Revenue by Regions (2012-2017)
Table Global HER2-negative Breast Cancer Revenue Market Share by Regions (2012-2017)
Table 2015 Global HER2-negative Breast Cancer Revenue Market Share by Regions
Table Global HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table North America HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table China HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table India HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Global HER2-negative Breast Cancer Consumption Market by Regions (2012-2017)
Table Global HER2-negative Breast Cancer Consumption Market Share by Regions (2012-2017)
Figure Global HER2-negative Breast Cancer Consumption Market Share by Regions (2012-2017)
Figure 2015 Global HER2-negative Breast Cancer Consumption Market Share by Regions
Table North America HER2-negative Breast Cancer Production, Consumption, Import & Export (2012-2017)
Table Europe HER2-negative Breast Cancer Production, Consumption, Import & Export (2012-2017)
Table China HER2-negative Breast Cancer Production, Consumption, Import & Export (2012-2017)
Table Japan HER2-negative Breast Cancer Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia HER2-negative Breast Cancer Production, Consumption, Import & Export (2012-2017)
Table India HER2-negative Breast Cancer Production, Consumption, Import & Export (2012-2017)
Table Global HER2-negative Breast Cancer Production by Type (2012-2017)
Table Global HER2-negative Breast Cancer Production Share by Type (2012-2017)
Figure Production Market Share of HER2-negative Breast Cancer by Type (2012-2017)
Figure 2015 Production Market Share of HER2-negative Breast Cancer by Type
Table Global HER2-negative Breast Cancer Revenue by Type (2012-2017)
Table Global HER2-negative Breast Cancer Revenue Share by Type (2012-2017)
Figure Production Revenue Share of HER2-negative Breast Cancer by Type (2012-2017)
Figure 2015 Revenue Market Share of HER2-negative Breast Cancer by Type
Table Global HER2-negative Breast Cancer Price by Type (2012-2017)
Figure Global HER2-negative Breast Cancer Production Growth by Type (2012-2017)
Table Global HER2-negative Breast Cancer Consumption by Application (2012-2017)
Table Global HER2-negative Breast Cancer Consumption Market Share by Application (2012-2017)
Figure Global HER2-negative Breast Cancer Consumption Market Share by Application in 2015
Table Global HER2-negative Breast Cancer Consumption Growth Rate by Application (2012-2017)
Figure Global HER2-negative Breast Cancer Consumption Growth Rate by Application (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffmann-La Roche HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche HER2-negative Breast Cancer Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis HER2-negative Breast Cancer Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer HER2-negative Breast Cancer Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AbbVie HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie HER2-negative Breast Cancer Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca HER2-negative Breast Cancer Market Share (2012-2017)
Table BioMarin Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BioMarin HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table BioMarin HER2-negative Breast Cancer Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb HER2-negative Breast Cancer Market Share (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eisai HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Eisai HER2-negative Breast Cancer Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly HER2-negative Breast Cancer Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of HER2-negative Breast Cancer
Figure Manufacturing Process Analysis of HER2-negative Breast Cancer
Figure HER2-negative Breast Cancer Industrial Chain Analysis
Table Raw Materials Sources of HER2-negative Breast Cancer Major Manufacturers in 2016
Table Major Buyers of HER2-negative Breast Cancer
Table Distributors/Traders List
Figure Global HER2-negative Breast Cancer Production and Growth Rate Forecast (2017-2022)
Figure Global HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2017-2022)
Table Global HER2-negative Breast Cancer Production Forecast by Regions (2017-2022)
Table Global HER2-negative Breast Cancer Consumption Forecast by Regions (2017-2022)
Table Global HER2-negative Breast Cancer Production Forecast by Type (2017-2022)
Table Global HER2-negative Breast Cancer Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

F. Hoffmann-La Roche
Novartis
Pfizer
AbbVie
AstraZeneca
BioMarin
Bristol-Myers Squibb
Eisai
Eli Lilly
Galena Biopharma
Incyte
Merck
Merck Serono
Merrimack
Nektar
Tesaro